Cash Jenna L, Bass Mark D, Campbell Jessica, Barnes Matthew, Kubes Paul, Martin Paul
School of Physiology & Pharmacology, Medical Sciences, University Walk, Bristol University, Bristol BS8 1TD, UK; William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK; Calvin, Phoebe, and Joan Snyder Institute for Infection, Immunity, & Inflammation, University of Calgary, Calgary, AB T2N 4N1, Canada.
School of Biochemistry, Medical Sciences, University Walk, Bristol University, Bristol BS8 1TD, UK.
Curr Biol. 2014 Jun 16;24(12):1406-1414. doi: 10.1016/j.cub.2014.05.006. Epub 2014 May 29.
Disorders of cutaneous repair can cause disability or death given that skin functions as a protective barrier against the external environment. The inflammatory response triggered by tissue damage is thought to play both positive (e.g., pathogen-killing) and negative (e.g., scarring) roles in repair. Inflammatory resolution mediators such as chemerin15 (C15) control the magnitude and duration of the inflammatory response; however, their role in wound repair and scarring is unknown. Here, we show that the C15 precursor, chemerin, and its receptor, ChemR23, are both upregulated after skin damage and that the receptor is expressed by macrophages, neutrophils, and keratinocytes. Dynamic live-imaging studies of murine cutaneous wounds demonstrate that C15 delivery dampens the immediate intravascular inflammatory events, including platelet adhesion to neutrophils, an important event in driving leukocyte recruitment. C15 administration indirectly accelerates wound closure while altering fibroblast-mediated collagen deposition and alignment to reduce scarring. Macrophage recruitment is restricted to the immediate wound site rather than spilling extensively into the adjacent tissue as in control wounds, and macrophage phenotype in C15-treated wounds is skewed toward a less inflammatory phenotype with reduced iNOS, increased Arginase-1, and lower wound tumor necrosis factor α (TNF-α) expression. Modulation of inflammatory resolution pathways in acute and chronic wounds may therefore provide a novel therapeutic avenue to improve repair and reduce scarring.
鉴于皮肤作为抵御外部环境的保护屏障,皮肤修复障碍可导致残疾或死亡。组织损伤引发的炎症反应被认为在修复过程中既发挥积极作用(如杀灭病原体)又发挥消极作用(如形成瘢痕)。诸如chemerin15(C15)等炎症消退介质控制着炎症反应的程度和持续时间;然而,它们在伤口修复和瘢痕形成中的作用尚不清楚。在此,我们表明C15前体chemerin及其受体ChemR23在皮肤损伤后均上调,且该受体由巨噬细胞、中性粒细胞和角质形成细胞表达。对小鼠皮肤伤口的动态实时成像研究表明,给予C15可减轻即刻的血管内炎症事件,包括血小板与中性粒细胞的黏附,这是驱动白细胞募集的一个重要事件。给予C15可间接加速伤口闭合,同时改变成纤维细胞介导的胶原蛋白沉积和排列以减少瘢痕形成。巨噬细胞募集局限于伤口即刻部位,而非像对照伤口那样广泛扩散至邻近组织,且C15处理伤口中的巨噬细胞表型倾向于炎症性较低的表型,iNOS减少、精氨酸酶-1增加且伤口肿瘤坏死因子α(TNF-α)表达降低。因此,调节急性和慢性伤口中的炎症消退途径可能提供一种改善修复和减少瘢痕形成的新治疗途径。